Altre lingue Wellbiotec Co., Ltd.

Azioni

A010600

KR7010600005

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 05/04/2024			Variaz. 5gg	Var. 1 gen.
545 ^KRW	-6,84%		-.--%	-54,77%

08/04	Wellbiotec Co., Ltd. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	Wellbiotec Co., Ltd. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Wellbiotec Co., Ltd.(KOSE:A010600) dropped from S&P Global BMI Index	16/04
Wellbiotec Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	08/04
Wellbiotec Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Wellbiotec Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Wellbiotec Co., Ltd. announced that it has received KRW 8.00000001 billion in funding from K-Impact Fund	13/06/23
Wellbiotec Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
Wellbiotec Co., Ltd. announced that it has received KRW 3 billion in funding from KH Feelux Co., Ltd.	26/03/23
Wellbiotec Co., Ltd. announced that it has received KRW 10 billion in funding from Sangsangin Plus Savings Bank Co.,Ltd., Sangsangin Savings Bank, Investment Arm	09/02/23
Wellbiotec Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Sangsangin Plus Savings Bank Co.,Ltd., Sangsangin Savings Bank, Investment Arm	07/02/23
KOSSEN Co., Ltd. cancelled the acquisition of additional 14.57% stake in Biogenicskorea Co., Ltd. from a group of sellers.	21/12/22
Wellbiotec Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
Wellbiotec Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/08/22
Wellbiotec Co., Ltd. announced that it expects to receive KRW 3 billion in funding from KH Feelux Co., Ltd.	21/06/22
Wellbiotec Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	12/05/22
Wellbiotec Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22/03/22
Wellbiotec Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21
Wellbiotec Co., Ltd. announced that it expects to receive KRW 9.99999891 billion in funding from Shin-oh Electronic Co.Ltd and another investor	22/10/21
Wellbiotec Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Wise Pacific Holdings Limited and another investor	14/04/21
Wellbiotec Co., Ltd. cancelled the transaction announced on January 2, 2019	26/03/21
Wellbiotec Co., Ltd. announced that it has received KRW 15 billion in funding	26/02/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Wellbiotec Co., Ltd.

Azioni

A010600

KR7010600005

Altre lingue

Filtri